表紙:ホルモン補充療法市場:世界の業界動向、シェア、規模、成長、機会、予測(2021~2026年)
市場調査レポート
商品コード
999772

ホルモン補充療法市場:世界の業界動向、シェア、規模、成長、機会、予測(2021~2026年)

Hormone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 106 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.68円
ホルモン補充療法市場:世界の業界動向、シェア、規模、成長、機会、予測(2021~2026年)
出版日: 2021年04月12日
発行: IMARC Services Private Limited
ページ情報: 英文 106 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ホルモン補充療法(HRT)は、人体に低レベルで存在するホルモンを補充するために使用されます。この治療法は、成長ホルモン欠乏症の患者、閉経に近づいている女性、性腺機能低下症に苦しむ高齢者に特に適しています。 HRTは、皮膚および口のパッチ(経皮)、ジェル、注射、インプラントなど、いくつかの形態で利用できます。ただし、HRTは、血栓、肝疾患、未治療の高血圧の病歴がある患者には適さない場合があります。この治療法には、腹部膨満、腫れ、吐き気、脚のけいれん、頭痛、消化不良、コレステロール値の上昇、赤血球数の増加などの副作用も含まれる場合があります。 世界のホルモン補充療法の市場規模は2020年に81億6千万米ドルの価値に達しました。

老人および新生児の人口におけるホルモン不均衡障害の発生率の急増は、主に市場の成長を推進しています。より安全性の高い結果をもたらす新しい治療オプションの必要性の高まりは、(HRT)ホルモン補充療法の需要をさらに押し上げています。さらに、新しいゲルベースの製剤の開発とともに、主要なプレーヤーによる積極的なマーケティングおよび直接販売キャンペーンは、これらの治療法の魅力的な市場を生み出します。さらに、消費者の意識の高まりと定期的に監視されている製剤の存在も、市場の成長を刺激する要因です。世界のホルモン補充療法市場は今後5年間で緩やかな成長を示すと予測されています。

当レポートでは、ホルモン補充療法市場について調査し、市場の概要とともに、製品別、塘路ルート別、疾患タイプ別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

第2章 範囲と調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界のホルモン補充療法市場

  • 市場概要
  • 市場パフォーマンス
  • COVID-19の影響
  • 価格分析
  • 製品別の市場セグメンテーション
  • 投与ルート別の市場セグメンテーション
  • 地域別の市場セグメンテーション
  • SWOT分析
    • 概要
    • 強み
    • 弱点
    • 市場機会
    • 脅威
  • バリューチェーン分析
    • 概要
    • 研究開発
    • 原材料調達
    • 製造
    • マーケティング
    • 流通
    • 最終用途
  • ポーターズファイブフォース分析
    • 概要
    • 買い手の交渉力
    • 供給企業の交渉力
    • 競合
    • 新規参入業者の脅威
    • 代替品の脅威

第6章 市場セグメンテーション、製品別

  • エストロゲン補充療法
  • ヒト成長ホルモン補充療法
  • 甲状腺補充療法
  • テストステロン補充療法
  • その他

第7章 市場セグメンテーション、投与ルート別

  • 経口
  • 非経口
  • 経皮吸収

第8章 市場セグメンテーション、疾患タイプ別

  • 閉経
  • 甲状腺機能低下症
  • 男性の性腺機能低下症
  • 成長ホルモン欠乏症
  • その他

第9章 市場セグメンテーション、地域別

  • 北米
  • 欧州
  • アジア太平洋
  • 中東とアフリカ
  • ラテンアメリカ

第10章 競合情勢

  • 市場構造
  • キープレーヤー
  • キープレーヤーのプロファイル
    • Abbott Laboratories
    • Bayer AG
    • Eli Lilly & Company
    • Roche
    • Hisamitsu Pharmaceutical Co. Inc.
    • Merck
    • Mylan NV
    • Novartis AG
    • Novo Nordisk A/S
    • Pfizer Inc
図表

List of Figures

  • Figure 1: Global: Hormone Replacement Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Hormone Replacement Therapy Market: Sales Value (in Billion US$), 2015-2020
  • Figure 3: Global: Hormone Replacement Therapy Market: Breakup by Product (in %), 2020
  • Figure 4: Global: Hormone Replacement Therapy Market: Breakup by Route of administration (in %), 2020
  • Figure 5: Global: Hormone Replacement Therapy Market: Breakup by Type of Disease (in %), 2020
  • Figure 6: Global: Hormone Replacement Therapy Market: Breakup by Region (in %), 2020
  • Figure 7: Global: Hormone Replacement Therapy Market Forecast: Sales Value (in Billion US$), 2021-2026
  • Figure 8: Global: Hormone Replacement Therapy Industry: SWOT Analysis
  • Figure 9: Global: Hormone Replacement Therapy Industry: Value Chain Analysis
  • Figure 10: Global: Hormone Replacement Therapy Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Hormone Replacement Therapy (Estrogen) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 12: Global: Hormone Replacement Therapy (Estrogen) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 13: Global: Hormone Replacement Therapy (Human Growth Hormone) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 14: Global: Hormone Replacement Therapy (Human Growth Hormone) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 15: Global: Hormone Replacement Therapy (Thyroid) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 16: Global: Hormone Replacement Therapy (Thyroid) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 17: Global: Hormone Replacement Therapy (Testosterone) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 18: Global: Hormone Replacement Therapy (Testosterone) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 19: Global: Hormone Replacement Therapy (Other Types) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 20: Global: Hormone Replacement Therapy (Other Types) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 21: Global: Hormone Replacement Therapy (Oral) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 22: Global: Hormone Replacement Therapy (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 23: Global: Hormone Replacement Therapy (Parenteral) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 24: Global: Hormone Replacement Therapy (Parenteral) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 25: Global: Hormone Replacement Therapy (Transdermal) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 26: Global: Hormone Replacement Therapy (Transdermal) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 27: Global: Hormone Replacement Therapy (Menopause) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 28: Global: Hormone Replacement Therapy (Menopause) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 29: Global: Hormone Replacement Therapy (Hypothyroidism) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 30: Global: Hormone Replacement Therapy (Hypothyroidism) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 31: Global: Hormone Replacement Therapy (Male Hypogonadism) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 32: Global: Hormone Replacement Therapy (Male Hypogonadism) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 33: Global: Hormone Replacement Therapy (Growth Hormone Deficiency) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 34: Global: Hormone Replacement Therapy (Growth Hormone Deficiency) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 35: Global: Hormone Replacement Therapy (Other Diseases) Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 36: Global: Hormone Replacement Therapy (Other Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 37: North America: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 38: North America: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 39: Europe: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 40: Europe: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 41: Asia Pacific: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 42: Asia Pacific: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 43: Middle East and Africa: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 44: Middle East and Africa: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2021-2026
  • Figure 45: Latin America: Hormone Replacement Therapy Market: Sales Value (in Million US$), 2015 & 2020
  • Figure 46: Latin America: Hormone Replacement Therapy Market Forecast: Sales Value (in Million US$), 2021-2026

List of Tables

  • Table 1: Global: Hormone Replacement Therapy Market: Key Industry Highlights, 2020 and 2026
  • Table 2: Global: Hormone Replacement Therapy Market Forecast: Breakup by Product (in Million US$), 2021-2026
  • Table 3: Global: Hormone Replacement Therapy Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
  • Table 4: Global: Hormone Replacement Therapy Market Forecast: Breakup by Type of Disease (in Million US$), 2021-2026
  • Table 5: Global: Hormone Replacement Therapy Market Forecast: Breakup by Region (in Million US$), 2021-2026
  • Table 6: Global: Hormone Replacement Therapy Market: Competitive Structure
  • Table 7: Global: Hormone Replacement Therapy Market: Key Players
目次
Product Code: SR1020B158_Report

Hormone replacement therapy (HRT) is used for replenishing the hormones that are present in low levels in the human body. This treatment is particularly favourable for patients with growth hormone deficiency, women nearing menopause and elderly people suffering from hypogonadism. HRT is available in several forms such as skin and mouth patches (transdermal), gels, injections and implants. However, HRT may not be suitable for patients who have a history of blood clots, liver disease and untreated high blood pressure. This therapy may also include some adverse effects like bloating, swelling, nausea, leg cramps, headaches, indigestion, increased cholesterol levels and a rise in the number of red blood cells. According to the latest report by IMARC Group, titled "Hormone Replacement Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026", the global hormone replacement therapy market reached a value of US$ 8.16 Billion in 2020.

A surge in the incidences of hormone imbalance disorders in the geriatric and neonatal populations is primarily driving the market growth. The rising need for new treatment options with better safety results is further boosting the demand for (HRT) hormone replacement therapy. Additionally, aggressive marketing and direct selling campaigns by the key players along with the development of new gel-based formulations creates an attractive market for these therapies. Moreover, increasing awareness among the consumers and the presence of regularly monitored formulations are some of the other drivers stimulating the growth of the market. Looking forward, IMARC Group expects the global hormone replacement therapy market to exhibit moderate growth during the next five years.

Market Summary:

Based on product, estrogen replacement therapy accounts for the majority of the market share. Other types include human growth hormone replacement therapy, testosterone replacement therapy, thyroid replacement therapy and others.

On the basis of route of administration, the report has segmented the market on the basis of oral, parenteral and transdermal segments.

On the basis of disease, the report has segmented the market on the basis of menopause, hypothyroidism, male hypogonadism, growth hormone deficiency and Others.

Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the largest market, accounting for the majority of the market share.

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Bayer AG, Eli Lilly & Company, Roche, Hisamitsu Pharmaceutical Co. Inc., Merck, Mylan, Novartis, Novo Nordisk and Pfizer.

This report provides a deep insight into the global hormone replacement therapy market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the hormone replacement therapy market in any manner.

Key Questions Answered in This Report:

  • 1. What was the global hormone replacement therapy market size in 2020?
  • 2. What will be the global hormone replacement therapy market outlook during the forecast period (2021-2026)?
  • 3. What are the global hormone replacement therapy market drivers?
  • 4. What are the major trends in the global hormone replacement therapy market?
  • 5. What is the impact of COVID-19 on the global hormone replacement therapy market?
  • 6. What is the global hormone replacement therapy market breakup by product type?
  • 7. What is the global hormone replacement therapy market breakup by route of administration?
  • 8. What is the global hormone replacement therapy market breakup by type of disease?
  • 9. What are the major regions in the global hormone replacement therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Hormone Replacement Therapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Price Analysis
  • 5.5 Market Breakup by Product
  • 5.6 Market Breakup by Route of Administration
  • 5.7 Market Breakup by Type of Disease
  • 5.8 Market Breakup by Region
  • 5.9 Market Forecast
  • 5.10 SWOT Analysis
    • 5.10.1 Overview
    • 5.10.2 Strengths
    • 5.10.3 Weaknesses
    • 5.10.4 Opportunities
    • 5.10.5 Threats
  • 5.11 Value Chain Analysis
    • 5.11.1 Overview
    • 5.11.2 Research and Development
    • 5.11.3 Raw Material Procurement
    • 5.11.4 Manufacturing
    • 5.11.5 Marketing
    • 5.11.6 Distribution
    • 5.11.7 End-Use
  • 5.12 Porters Five Forces Analysis
    • 5.12.1 Overview
    • 5.12.2 Bargaining Power of Buyers
    • 5.12.3 Bargaining Power of Suppliers
    • 5.12.4 Degree of Competition
    • 5.12.5 Threat of New Entrants
    • 5.12.6 Threat of Substitutes

6 Market Breakup by Product

  • 6.1 Estrogen Replacement Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Human Growth Hormone Replacement Therapy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Thyroid Replacement Therapy
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Testosterone Replacement Therapy
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Parenteral
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Transdermal
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Type of Disease

  • 8.1 Menopause
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hypothyroidism
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Male Hypogonadism
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Growth Hormone Deficiency
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Europe
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Asia Pacific
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Competitive Landscape

  • 10.1 Market Structure
  • 10.2 Key Players
  • 10.3 Profiles of Key Players
    • 10.3.1 Abbott Laboratories
    • 10.3.2 Bayer AG
    • 10.3.3 Eli Lilly & Company
    • 10.3.4 Roche
    • 10.3.5 Hisamitsu Pharmaceutical Co. Inc.
    • 10.3.6 Merck
    • 10.3.7 Mylan NV
    • 10.3.8 Novartis AG
    • 10.3.9 Novo Nordisk A/S
    • 10.3.10 Pfizer Inc